The total protein expression of RCC2 was considerably elevated in pancreatic adenocarcinoma (PAAD), COAD, ovarian serous cystadenocarcinoma (OV), GBM and BRCA tumors compared to normal tissues (Figure 1B). This evidence concerns the gene RCC2 and glioblastoma.